We investigated the usefulness of immunological methods for presumptive detection of stimulants found in sports drug testing. The ingestion of substances that show no cross-reactivity in tests commercially available for the detection of amphetamines can produce positive results in the urine. Human metabolism contributes to the positive results of some urine samples when the parent compound does not cross-react with the antibodies of the assay. Urine samples from healthy volunteers given stimulants were tested by chromatographic methods and by two different fluorescence polarization immunoassays (FPIA) from Abbott Laboratories for the analysis of amphetamines. According to the results obtained, we classified stimulants into four groups: detectable stimulants that gave rise to amphetamine by human metabolism (group 1); detectable ephedrines and related compounds, appearing in the urine either as parent compounds or originated by metabolism (group 2); detectable stimulants that displayed actual cross-reactivity with amphetamine tests (group 3); and stimulants not detected by FPIA (group 4). Most of the true doping cases due to the ingestion of stimulants may be detected by FPIA. The specificity of the results may be increased by combining immunological assays with different antibodies.
Introduction
Some of the advantages of immunological analytical methods include rapid and simple performance, relatively low cost of reagents, high sensitivity when necessary, and inexpensive equipment. Immunological techniques that use antibodies with cross-reactivity toward a broad group of substances may be useful for drug screening. In some cases, chemically related substances not originally included in the design of the method may even be analyzed (1, 2) .
Screening a group of substances is particularly useful when the expected prevalence of positive cases for each individual substance is low, such as in sports drug testing. Immunological methods, however, are not routinely used in the pre-sumptive screening of drugs in human doping control (3) (4) (5) as compared with other related fields in clinical toxicology, such as drugs-of-abuse testing or horse dope testing. This may be a result of the extensive list of substances to be analyzed (6) as compared, for example, with those in the field of drugs-ofabuse testing (7) .
We have shown that enzyme immunoassay with polyclonal antibodies performed for the detection of amphetamine and methamphetamine could detect a number of related substances of interest in sports drug testing, and most of these substances are phenylalkylamine derivatives (8, 9) . Moreover, specificity of the test could be increased by using an additional chemical reaction. The pretreatment of samples with alkaline periodate eliminated the cross-reaction of cr phenyl ethylamines (i.e., ephedrine derivatives) (10, 11) . Chemical reactions can therefore be combined with immunological techniques to enhance specificity.
We also found that some substances, such as amfepramone, for which no cross-reactivity has been stated by the manufacturers, gave rise to urinary metabolites with high cross-reactivity when administered to humans (8) . It seems that there is a marked difference between results of cross-reactivity studies performed by manufacturers on urine specimens spiked with the parent compound and those obtained from healthy subjects given the same compound.
The concept of biological cross-reactivity, which is based on the cross-reactivity of a particular compound and its metabolites, refers to the capability of the immunological test to detect the presence of this substance in a biological fluid. There are many factors that influence the final urinary excretion of a given substance, including the dose administered, interindividual variations in drug metabolism and body clearance, and sample collection time. However, when crossreactivity studies of substances found in sports drug testing are performed using the natural urinary metabolites, a better picture of the actual detection capability of a particular immunological test is obtained (12) .
We conducted this study to identify doping agents that can be detected by fluorescence polarization immunoassay (FPIA) in urine for the following purposes: (a) to assess the presence of cross-reactivity after the ingestion of stimulants; (b) to identify urinary metabolites that can explain some unexpected results in terms of cross-reactivity as compared with the cross-reactivity of the parent compound through the use of chromatographic techniques; and (c) to evaluate the combined use of different immunological assays for enhancing specificity of the test.
Experimental

Samples
Excretion studies involving drug administration and urine collection were performed with healthy male volunteers. The study protocol was approved by the Ethical Committee of Hospital del Mar (Barcelona, Spain) and authorized by the National Department of Health (reference number 88/135). Compounds classified as banned substances (stimulant class) were administered at the doses recommended by the International Olympic Committee (ICO) Medical Commission. Doping class A stimulants are shown in Table I (those used in this study are shown in bold face along with the dose, which was given orally). The collection periods performed were usually 0-8 and 8-24 h, and spot urine specimens were collected after 24 h. Volunteers were under medical supervision throughout the study.
Procedure
Urinary excretion studies were tested simultaneously by FPIA (Abbott Laboratories, Chicago, IL) and by chromatographic methods. Urine specimens were analyzed by FPIA tests using a TDx instrument, and the instructions of the manufacturer were followed (13) . FPIA assays used a six-point calibration curve. The cutoff values established for positive cross-reactivity corresponded to the sensitivity limits reported by the manufacturer. Positive results could also be reported in quantitative terms, that is, a response equivalent to a given amount of the calibration substance. Two FPIA assays for the detection of amphetamines were used, "amphetamine class" and "amphetamine/methamphetamine Ir' tests. The amphetamine class test is calibrated against d,l-amphetamine, and the amphetamine/methamphetamine II test is calibrated against damphetamine. According to the manufacturer, both tests have the same limit of sensitivity at 100 ng/mL, although the amphetamine class test was designed for the detection of drugs structurally related to amphetamine (amphetamine congeners, substitutes, analogues, and derivatives), and the amphetamine/ methamphetamine II test is a more specific assay designed to detect amphetamine and methamphetamine.
Two screening chromatographic procedures were used. The first consisted of the analysis of urine made alkaline and extracted with diethyl ether with a salting out effect (14) . The final extracts were analyzed by capillary gas chromatography in conjunction with a specific nitrogen-phosphorous detector. This procedure is suitable for the analysis of highly volatile nitrogen compounds, such as those contained in most stimulants. In the second chromatographic method, samples were extracted with a solid-phase extraction procedure (15) after being submitted to an enzymatic hydrolysis. The final residue was selectively derivatized with N-methylsilyltrifluoroac-
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Journal of Analytical Toxicology, Vol. 20, May/June 1996 etamide and N-methyl bistrifluoroacetamide (MSTFA/MBTFA) and analyzed by gas chromatography-mass spectrometry (GC-MS) (15) . This procedure is suitable for substances that are mainly excreted in urine as glucuronide conjugates and in which the derivatization step enhances the chromatographic properties of hydrolyzed compounds (i.e., some of the most polar metabolites of stimulants). In both procedures, the identification of all stimulants and their metabolites was ultimately confirmed by GC-MS.
Results
Stimulants were classified into four groups according to the metabolites detected by chromatographic methods and the immunological response obtained. Group 1 included stimulants that gave rise to amphetamine in their metabolism. Even if some of the parent compounds administered to healthy volunteers did not show cross-reactivity with antibodies (i.e., spiked urine specimens with unchanged clobenzorex, fenproporex, and mefenorex gave negative responses in both tests), the final result was positive because of the presence of amphetamine via biotransformation. Metabolites observed by chromatographic methods and their quantitation and results obtained with the amphetamine class and amphetamine/methamphetamine II GC-NPD = Gas chromatography-nitrogen-phosphorous detection. # n.a. = Not assayed. "n.d. = None detected. Response less than the sensistivity of the assay (100 n~mL). ttn.q. = Identified but not quantitated Discussion Upon administration, substances corresponding to group 1 may be detected in urine using highly specific tests against amphetamine. The response obtained is mainly due to the detection of amphetamine generated by human metabolism. One of the interesting examples of substances in group 2 is amfepramone. As parent compound, it has a low cross-reactivity for the amphetamine class test, but urine specimens from individuals given this substance are positive for this test because most of its metabolites are ephedrine-related substances; amfepramone may even be absent from the urine because of its high hepatic clearance. In the miscellaneous group 3, positive responses obtained can be considered real cross-reactions, although antibodies were not originally directed to detect either the parent compounds or the metabolites generated.
The present study confirms that human metabolism contributes to the positive results of some urine samples in cases in which the parent compound does not express cross-reactivity with the antibodies of the assay. This finding is of interest GC-NPD = Gas chromatography-nitrogen-phosphorous detection. # n.d. = None detected. Response less than the sensitivity of the assay (100 ng/mL). **n.q. = Identified but not quantitated.
'i'tn.a. = Not assayed.
because of its application to immunological tests in sports drug testing and because it can be extended to use in the fields of forensic toxicology and drugs-of-abuse testing. In fact, a similar approach had long been applied when designing immunological tests for benzodiazepines in which oxazepam or nordiazepam were chosen as the metabolic intermediates of several benzodiazepines that were the target of these techniques.
A few substances included in the International Olympic Committee's (IOC) stimulant class A were not available. Consequently, excretion studies in humans were not performed, and, therefore, the substances were not tested in the present protocol. However, from what is known about related substances, it can be anticipated that some of them will show a positive cross-reactivity with some of the tests evaluated in this study. Therefore, amphetamine derivatives such as benzphetamine, furfenorex, and ethylamphetamine can be included in group 1 because amphetamine is one of their urinary metabolites. Other nonrelated amphetamine compounds such as selegiline and famprofazone can also be included in group 1 because they give rise to methamphetamine when metabolized.
Methylephedrine is an ephedrine derivative and can be classified in group 2. In the cases of chlorphentermine and propylhexedrine, the manufacturer has described a cross-reactivity with the parent compound in spiked urine specimens (13) ; the substances can thus be classified in group 3.
Finally, the following additional substances, listed in stimulant class A of the IOC Medical Commission, were not included in the present protocol: caffeine, cocaine, clorprenaline, pemoline, pentetrazol, and pyrovalerone. Nevertheless, our previous experience with real positive cases in which these substances were ingested indicated that, as expected by their chemical structure, negative results would be obtained in both immunological tests.
Specificity of the immunological results can be increased by combining results of techniques that use antibodies that are directed to structurally similar compounds with different crossreactivities. Examples are the substances included in group 2, which reacted to the amphetamine class assay but did not show any type of cross-reactivity in the amphetamine/methamphetamine II test. The contrasting case of pholedrine and amineptine, which only showed cross-reactivity in this supposed "specific" test, is also of interest.
Because IOC lists (6) are "open" to other substances showing pharmacological actions and/or chemical structures related to the specific substances listed (see Table [ ), biological crossreactivity may appear with new abused substances. In these circumstances, the use of immunological methods would be very helpful in early detection of new trends in drug abuse.
Using immunological methods with low substance specificity to detect a broader range of substances can be very helpful if used judiciously. A subsequent confirmation of presumptive positive cases by chromatographic and spectrometric methods is necessary to determine the actual identity of the detected compounds. When substances that were reported in the last 4 years by IOC accredited laboratories as positive and belonging to the class A stimulants were reviewed, as many as 95% of cases detected by official chromatographic and spectrometric methods (16) would have been easily detected by combining both FPIA amphetamine tests.
